id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0525-0010,FDA,FDA-2002-E-0525,Patent Term Extension Application - Supporting Material - Part 1,Supporting & Related Material,APP-Application,2008-10-30T04:00:00Z,2008,10,,,2008-10-30T16:20:22Z,,0,0,090000648068a7e8
FDA-2002-E-0525-0012,FDA,FDA-2002-E-0525,Patent Term Extension Application - Supporting Material - Part 3,Supporting & Related Material,APP-Application,2008-10-30T04:00:00Z,2008,10,,,2008-10-30T16:20:24Z,,0,0,090000648068a828
FDA-2002-E-0525-0013,FDA,FDA-2002-E-0525,Patent Term Extension Application - Supporting Material - Part 4,Supporting & Related Material,APP-Application,2008-10-30T04:00:00Z,2008,10,,,2008-10-30T16:20:26Z,,0,0,090000648068a840
FDA-2002-E-0525-0007,FDA,FDA-2002-E-0525,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2008-10-30T04:00:00Z,2008,10,2008-10-30T04:00:00Z,,2008-10-30T16:19:40Z,,0,0,090000648068a88e
FDA-2002-E-0525-0009,FDA,FDA-2002-E-0525,"U.S. Patent and Trademark Office to George Wheeler, McAndrews, Held & Malloy LTD - Letter",Other,LET-Letter,2008-10-30T04:00:00Z,2008,10,2008-10-30T04:00:00Z,,2008-10-30T16:19:43Z,,0,0,090000648077358e
FDA-2002-E-0525-0011,FDA,FDA-2002-E-0525,Patent Term Extension Application - Supporting Material - Part 2,Supporting & Related Material,APP-Application,2008-10-30T04:00:00Z,2008,10,,,2008-10-30T16:20:23Z,,0,0,090000648068a818
FDA-2002-E-0525-0008,FDA,FDA-2002-E-0525,"USPTO to McAndrews, Held & Mallory LTD - Notice of Final Determination - Letter",Other,LET-Letter,2008-10-30T04:00:00Z,2008,10,2008-10-30T04:00:00Z,,2008-10-30T16:19:42Z,,0,0,090000648068a8ad
FDA-2002-E-0525-0006,FDA,FDA-2002-E-0525,Determination of Regulatory Review Period fo Purposes of Patent Extension; GALILEO INTRAVASCULAR RADIOTHERAPY SYSTEM,Notice,N-Notice,2007-05-21T04:00:00Z,2007,5,2007-05-18T04:00:00Z,2007-07-21T03:59:59Z,2008-07-17T19:45:56Z,,0,0,09000064804a5768
FDA-2002-E-0525-0005,FDA,FDA-2002-E-0525,FDA/CDER to U.S. Patent and Trademark Office,Other,LET-Letter,2007-05-17T04:00:00Z,2007,5,,,2008-04-12T01:18:59Z,,0,0,09000064804a5767
FDA-2002-E-0525-0004,FDA,FDA-2002-E-0525,USPTO to FDA/CDER -  Letter,Other,LET-Letter,2007-04-13T04:00:00Z,2007,4,,,2008-07-17T19:40:25Z,,0,0,09000064804a5766
FDA-2002-E-0525-0003,FDA,FDA-2002-E-0525,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2002-11-05T05:00:00Z,2002,11,,,2008-07-17T19:38:07Z,,0,0,09000064804a5765
FDA-2002-E-0525-0001,FDA,FDA-2002-E-0525,USPTO to FDA/CDER - Letter,Other,LET-Letter,2002-04-16T04:00:00Z,2002,4,,,2008-07-17T19:29:37Z,,0,0,09000064804a5758
FDA-2002-E-0525-0002,FDA,FDA-2002-E-0525,USPTO to FDA/CDER - Letter,Other,LET-Letter,2002-04-16T04:00:00Z,2002,4,,,2008-07-17T19:32:23Z,,0,0,09000064804a5764